ALGS vs CVS · rev $3.6M vs P/E 16, rev $402.07B
Aligos Therapeutics Inc (ALGS) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
ALGS currently screens at market cap $44.1M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the ALGS and CVS stock pages for the full models.
Not investment advice.